The spreading characteristic of a tissue-culture-modified laryngotracheitis virus (LTV) was demonstrated in chickens under both laboratory and field conditions. An enzyme-linked immunosorbent assay was used to measure serum antibodies to LTV in experimental chickens. Contact controls developed immunity comparable to that of vaccinates and were able to resist challenge with a virulent LTV inoculated into the infraorbital sinus.
Laryngotracheitis (LT) is an acute respiratory infection of chickens and is caused by a herpesvirus. 11 The incidence of LT outbreaks has been increasing in many poultry producing areas in the USA. 4 Modified live LT vaccines are widely used for prophylactic immunization; however, these vaccine viruses can increase in virulence following bird-to-bird passage. 10 Involvement of vaccine viruses in LT outbreaks was confirmed by recent studies comparing vaccine viruses and field isolates. 8, 9 In an attempt to eradicate the disease, a resolution was passed by the US Animal Health Association Committee on Transmissible Diseases of Poultry and Other Avian Species to restrict and gradually prohibit the use of live LT vaccines. 3 This approach created some concerns by some veterinarians because of multiage farms in some states. The need for LT vaccines that will not be shed by the vaccinated birds becomes obviously essential. Laryngotracheitis vaccine virus of chicken embryo origin spreads horizontally; 1 however, conflicting information is available on the spreading characteristics of LT vaccine of tissue culture (TC) origin.
Materials and methods
LT vaccine. A TC-origin product was obtained from the manufacturer. a Recommendations of the manufacturer in regard to vaccine reconstitution, handling, and vaccination procedure were strictly followed. The vaccine was administered by eye drop using plastic dropper applicators supplied in the vaccine package.
On-farm trial 1. Fifty-thousand commercial caged layers were vaccinated at 15 wk of age. At 4 days postvaccination, 15 chickens that had been removed from the flock and held in isolation were returned to the vaccinated group to serve as native contacts. Blood samples were collected from vaccinates and contacts before vaccination and at 6 wk post-vaccination and were checked for antibodies to LT virus (LTV) by enzyme-linked immunosorbent assay (ELISA). 14 On-farm trial 2. Twenty-two thousand commercial caged layers on the same farm (different building) as those used in trial 1 were vaccinated at 15 wk of age. At 6 wk postvaccination, 15 specific-pathogen-free (SPF) female chickens from a flock maintained by the Department of Avian and Aquatic Animal Medicine at Cornell University were added to the vaccinated flock. Vaccinates were bled for ELISA before vaccination. Contacts and vaccinates were bled again before contact and 6 wk later. Trial 3. Fifteen SPF female chickens were vaccinated at 10 wk of age. Fifteen 10-wk-old female SPF contact controls were housed with vaccinates 4 days postvaccination. Chickens were maintained in battery cages (5 vaccinates and 5 contacts) in a single isolation unit in the Poultry Virus Isolation Building at Cornell University. Blood samples for ELISA were collected from both groups before vaccination and at 6 wk postvaccination. Chickens in both groups plus an additional 15 susceptible SPF controls were then challenged with a virulent LTV.
Challenge infection. Challenge with LTV was carried out
to evaluate resistance of birds in trial 3. Vaccinates, contacts, and susceptible SPF chickens were challenged with 0.1 ml of virulent LTV ( 10 4.7 EID 50 /ml) inoculated into the infraorbital sinus. Exposed birds were observed for 7 days following challenge for clinical signs. Birds were euthanized, necropsied, and examined for gross lesions. Segments of trachea immediately caudal to the larynx were placed in 10% buffered neutral formalin and were sectioned and stained with hematoxylin and eosin (HE) by routine procedure. Microscopic lesions were scored on a scale of 0-5 (normal to very severe) as described in previous reports. 10 A composite score for each group was determined by adding individual scores and dividing the sum by the total number examined. For evaluation purposes, scores of 0 and 1 were considered negative for LTV infection; scores 2-5 were considered positive.
Results
Antibodies to LTV were detected in birds in all trials ( Figs. 1-3 ). All SPF vaccinates and contacts responded strongly, and titers were considerably higher than those all 15 susceptible SPF controls developed mild respidetected in the commercial chickens. Vaccinates and ratory signs (nasal discharge, rales) and swelling at the contacts in all trials developed no respiratory or eye site of inoculation without mortality. Lesions in the reactions to the vaccine. trachea varied from mild reddening of the mucosa to Upon challenge, both vaccinates and contacts in trial severe hemorrhagic exudate in the lumen and mild to 3 were 100% resistant. They displayed no clinical signs, severe microscopic lesions (mean score = 3.3) typical gross pathology, or microscopic lesions. In contrast, of LT. 11 Figure 2 . Antibody titers to laryngotracheitis virus in commercial vaccinates and SPF contacts in trial 2. ELISA antibody titers in the SPF chickens are higher than those detected in the commercial chickens. Figure 3 . Antibody titers to laryngotracheitis virus in SPF vaccinates and SPF contacts in trial 3. SPF chickens responded strongly, and titers were considerably higher than those detected in the commercial chickens.
Discussion
Antibodies to LTV were detected in contact birds in all trials, indicating that TC-modified LTV was shed by vaccinates. Although data from trials 1 and 2 support this conclusion, the possibility of concurrent exposure to field virus was questioned. However, horizontal spread of vaccine virus was confirmed in trial 3, which was conducted with SPF birds held in strict isolation. Seroconversion and solid resistance to challenge observed in the contacts provided strong evidence that vaccinates do shed TC-modified LTV.
An ELISA was used to verify exposure o to LTV. The ELISA is rapid and can detect with high sensitivity and specificity. 14 In trial was less predictive of immunity than was f contacts antibody 3, ELISA challenge with virulent virus. Serum antibody titers falling into the ELISA titer group 0 were observed in 4 of 15 vaccinates and 4 of 15 contacts, yet 100% of both groups resisted challenge.
The conclusion that shedding of vaccine virus can occur agrees with previous reports. 5, 6 However, those studies were conducted with vaccine that apparently consisted of a mixture of virulent and nonvirulent viruses (Dr. T. M. Schwartz, Schering-Plough Corp., personal communication). The vaccine virus was subsequently cloned and is presently claimed by the manufacturer in the vaccine insert to consist only of mild attenuated virus that does not spread or seed the premises with virus. Thus, the present findings conflict with the claims.
Concerns over horizontal transmission of vaccine
virus is based on the observation that modified live LT vaccine viruses of chicken embryo origin can increase in virulence after bird-to-bird passage. 10 This transmission could occur when vaccine is administered incorrectly so that vaccination fails to provide immunity to many birds in the flock or when biosecurity measures fail to prevent spread of vaccine virus to unvaccinated flocks. 10 Recent field outbreaks of LT may have been due to vaccinal virus strains, possibly as the result of reversion of those strains to parentaltype virulence. 8, 9 Unlike the chicken embryo vaccine, the TC-modified LTV used in this study did not revert to virulence after 20 back passages. 10 Studies have shown that both wild and vaccine strains of LTV establish latency with subsequent shedding over a period of up to 15 months. 2, 7, 13 Latency can be a major biological survival mechanism of the LTV in chicken populations. Stress factors such as onset of lay and moving birds from growing to laying houses enhance shedding of LTV by vaccinated chickens. 12 The present study provides evidence that birds vaccinated with TC-modified LTV will shed the virus and that contact chickens will rable to that of vaccinates. 
